Hemiplegia — Clinical Documentation Guide (2026)

🔍 Definition

Hemiplegia is paralysis (complete loss of voluntary motor function) affecting one side of the body — the arm, leg, and often the face on the same side. The term hemiparesis refers to weakness rather than complete paralysis; however, per ICD-10-CM Official Guidelines, both hemiplegia and hemiparesis are captured under the same G81 category — the distinction between complete paralysis and weakness does not change code assignment.

The lesion responsible for hemiplegia is typically located in the contralateral cerebral hemisphere (motor cortex or internal capsule), the ipsilateral brainstem, or the cervical spinal cord. The etiology drives both clinical management and ICD-10-CM code selection: post-stroke sequelae (I69.xx), traumatic brain injury sequelae (S06.x with 7th character S), primary structural lesions, or other neurological diseases each map to different code families.

Accurate documentation must capture: (1) laterality — which side of the body is affected; (2) dominance — whether the affected side is the patient’s dominant or nondominant side; (3) type — flaccid vs. spastic; and (4) cause — this determines whether the principal sequela code family is G81.xx, I69.xx, or another category. According to CMS FY2026 ICD-10-CM Official Coding Guidelines, if documentation does not specify dominance, right-sided hemiplegia is coded as dominant and left-sided as nondominant; for ambidextrous patients, either side is coded dominant.

🗂️ Alternative Terminology

🩺 Signs & Symptoms

Hemiplegia presents with a constellation of motor and associated neurological findings depending on the level and cause of the lesion:

• Motor: Paralysis or significant weakness of the arm, hand, leg, and lower face on one side. In spastic hemiplegia, increased tone (hypertonia), brisk deep tendon reflexes, and Babinski sign (extensor plantar response) are characteristic. In flaccid hemiplegia (often acute phase or lower motor neuron origin), tone is reduced and reflexes are diminished.
• Gait: Circumduction gait (spastic leg swings outward), scissor gait in bilateral spastic involvement, or steppage gait with foot drop.
• Upper extremity posturing: Shoulder adduction, elbow flexion, wrist/finger flexion (hemiplegic posture).
• Spasticity: Velocity-dependent increase in muscle tone, often measured by the Modified Ashworth Scale (MAS 0–4) or Tardieu Scale. Spasticity impairs ADLs, causes pain, and is a major rehabilitation target.
• Dysphagia: Present in up to 50% of post-stroke hemiplegia; coded separately (I69.391 dysphagia following cerebral infarction, or R13.1x if acute).
• Aphasia / dysphasia: When dominant hemisphere is affected; coded separately (I69.320 aphasia following cerebral infarction).
• Hemianopia: Visual field loss on the hemiplegic side.
• Sensory loss: Hemisensory deficits (pain, temperature, proprioception) contralateral to the lesion.
• Cognitive / behavioral: Hemispatial neglect, depression, pseudobulbar affect.
• Bowel and bladder dysfunction: Neurogenic bladder, incontinence.
• Shoulder pain: Subluxation of the hemiplegic shoulder is common, causing chronic pain.

🧭 Differential Diagnosis

📋 Clinical Indicators for Coders/CDI

🦴 Anatomy & Pathophysiology

The primary motor cortex (Brodmann area 4) in the precentral gyrus of the frontal lobe controls voluntary motor function via the corticospinal (pyramidal) tract. Upper motor neuron (UMN) axons descend ipsilaterally through the corona radiata → internal capsule (posterior limb) → cerebral peduncles → brainstem → decussate at the pyramidal decussation in the medulla → descend as the lateral corticospinal tract in the contralateral spinal cord → synapse on lower motor neurons (LMN) in the anterior horn.

A unilateral lesion anywhere along this pathway before the decussation causes contralateral hemiplegia; a lesion below the decussation (e.g., cervical cord hemicord lesion) causes ipsilateral hemiplegia.

Flaccid vs. Spastic Phases

• Flaccid (acute/shock) phase: Immediately after UMN injury, the spinal cord below the lesion enters a state of “spinal shock” — reflexes are absent, tone is reduced, paralysis is flaccid. This may persist days to weeks. Coded as G81.0x.
• Spastic (chronic) phase: As spinal cord circuits reorganize (weeks to months after UMN injury), hyperreflexia, clonus, increased tone, and spasticity emerge due to loss of inhibitory corticospinal control. Coded as G81.1x. Spasticity driven by alpha motor neuron disinhibition is the target of baclofen, botulinum toxin, and physical therapy.

Common Etiologies and Lesion Locations

• Ischemic stroke: Middle cerebral artery (MCA) occlusion → contralateral face + arm > leg hemiplegia; internal capsule lacunar infarct → pure motor hemiplegia.
• Hemorrhagic stroke: Hypertensive hemorrhage most often in putamen/internal capsule.
• TBI: Diffuse axonal injury or focal contusion in motor areas.
• Demyelination (MS): Plaque in corticospinal tract.
• Brainstem lesion: Produces crossed (alternating) hemiplegia — ipsilateral cranial nerve palsy + contralateral hemiplegia.
• Spinal cord — Brown-Séquard (G83.81): Hemisection → ipsilateral UMN paralysis + ipsilateral proprioception loss + contralateral pain/temperature loss.

💊 Medication Impact / Treatment

Spasticity Management

• Baclofen (oral): GABA-B agonist; first-line for spasticity. Intrathecal baclofen pump (ITB) indicated for severe spasticity unresponsive to oral therapy — 62361–62370 for pump implantation/revision/refill + J0475/J0476 for intrathecal baclofen drug.
• Botulinum toxin type A (onabotulinum toxin A): Chemodenervation of spastic extremity muscles. CPT 64615 (chemodenervation of muscle — upper limb, trunk, or head/neck) or 64616 (lower extremity). Drug code J0585 (onabotulinumtoxinA, per unit). Dosing typically 100–400 units per session; repeat every 12–16 weeks. MAS ≥2 supports medical necessity.
• Tizanidine, cyclobenzaprine, dantrolene: Alternative oral antispastics. Dantrolene acts peripherally at muscle level (ryanodine receptor).
• Diazepam: GABA-A agonist; used cautiously due to sedation and dependence risk.

Stroke Secondary Prevention (affects comorbidity coding)

• Antiplatelet therapy (aspirin, clopidogrel) for ischemic stroke — Z79.82
• Anticoagulation (warfarin Z79.01, DOAC Z79.01) for AF-related stroke
• Statins — Z79.899
• Antihypertensives — hypertension I10 should always be coded with stroke sequela

Neuroprotective and Emerging Therapies

Constraint-induced movement therapy (CIMT) restricts the unaffected limb to force use of the hemiplegic limb — coded via CPT 97530 therapeutic activities. Transcranial magnetic stimulation (TMS) and brain–computer interfaces are investigational. Functional electrical stimulation (FES) for foot drop.

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines (FY2026)

The following guidelines govern hemiplegia coding under FY2026 ICD-10-CM Official Coding Guidelines (CMS):

Dominance Default Rule (Guideline I.C.6.a)

When documentation does not specify which side is dominant, apply the following defaults per the ICD-10-CM Tabular List instructional notes:

• Right-sided hemiplegia/hemiparesis → dominant
• Left-sided hemiplegia/hemiparesis → nondominant
• Ambidextrous patient + either side → dominant
• Right-handed patient + left-sided → nondominant
• Left-handed patient + right-sided → nondominant

Sequencing: Acute Stroke vs. Sequela

During an acute stroke admission, assign the appropriate I63.xx or I60-I62 code as principal diagnosis. G81.xx is assigned as an additional code if hemiplegia is documented as a current condition. Per Official Guidelines Section I.C.9.d, when a patient is admitted for rehabilitation or follow-up after a stroke and the neurological deficits persist, assign codes from category I69 (Sequelae of cerebrovascular disease) as the principal/first-listed diagnosis. The I69.xx code combination fully captures the history of stroke — do not assign both Z86.73 (history of TIA) and I69.xx; the I69 code subsumes the history.

Hemiplegia vs. Hemiparesis

The ICD-10-CM Index directs both “hemiplegia” and “hemiparesis” to the same codes in category G81 and I69.3x. The clinical distinction between complete paralysis and partial weakness does not affect code selection but should be documented for severity and care-planning purposes.

Late Effects / Sequela Coding (7th Character S)

For hemiplegia resulting from traumatic brain injury, assign the appropriate S06.xx code with 7th character S (sequela) as the sequela code, followed by G81.xx as the manifestation. Per Official Guidelines Section I.C.19.a, the injury code with 7th character S precedes the manifestation code.

Bilateral Hemiplegia Subcodes

FY2026 includes bilateral-specific subcategories: G81.03 (bilateral dominant flaccid) and G81.04 (bilateral nondominant flaccid); G81.13 (bilateral dominant spastic) and G81.14 (bilateral nondominant spastic). These apply when bilateral corticospinal tract lesions produce bilateral motor deficits.

G83.xx — Other Paralytic Syndromes

Category G83 captures paralytic syndromes outside the hemiplegia spectrum. Instructional notes require coding the underlying cause first (e.g., spinal cord lesion, stroke) when applicable. G83.5 (locked-in syndrome) and G83.81 (Brown-Séquard) have no meaningful etiology-based subcategories and are complete codes.

🔢 ICD-10-CM Code Set (FY2026)

Category G81 — Hemiplegia and Hemiparesis

Category I69.35x — Hemiplegia/Hemiparesis Following Cerebral Infarction (Critical RAF Codes)

Other I69.xx Sequela Codes for Hemiplegia

Category G83 — Other Paralytic Syndromes

Additional Related Codes

🔎 Indexing

Use the ICD-10-CM Alphabetic Index as follows:

• Hemiplegia → G81.90; then subterm by type (flaccid G81.00, spastic G81.10) and laterality
• Hemiparesis → see Hemiplegia
• Sequelae, stroke, hemiplegia → I69.35- (infarction); I69.05- (subarachnoid); I69.15- (intracerebral); I69.25- (other hemorrhage); I69.95- (unspecified CVD)
• Paralysis — spastic — see Hemiplegia, spastic
• Monoplegia, lower limb → G83.1-; upper limb → G83.2-
• Diplegia (upper limbs) → G83.0
• Locked-in state → G83.5
• Brown-Séquard syndrome → G83.81
• Todd’s paralysis / postepileptic → G83.84
• Cauda equina syndrome → G83.4
• Sequelae, injury (traumatic), brain — late effect → S06.xx with 7th char S; manifestation G81.xx

🏥 CPT (2026)

🧾 HCPCS (2026)

📚 AHA Coding Clinic (Recent Guidance)

The following AHA Coding Clinic advisories are relevant to hemiplegia documentation and coding:

• Post-Stroke Hemiplegia vs. Z86.73: Coding Clinic has consistently advised that when a patient presents with residual neurological deficits from a prior stroke — including hemiplegia, hemiparesis, aphasia, or dysphagia — the appropriate code is from category I69, not Z86.73. Z86.73 is reserved for resolved strokes with no remaining deficits. Coders and CDI specialists should query providers to distinguish between these two scenarios in any patient with a stroke history.
• Dominance in Hemiplegia: Coding Clinic has confirmed that the default coding rules in the Tabular List (right = dominant, left = nondominant when not specified) are the appropriate defaults, and that providers are not required to explicitly document “dominant” or “nondominant” — the coder applies the default.
• Hemiplegia and Hemiparesis — Same Codes: Coding Clinic has affirmed that “hemiparesis” is classified to the same category as “hemiplegia” in ICD-10-CM, reflecting the tabular equivalency of the two terms for coding purposes.
• Sequela of TBI with Hemiplegia: When a patient presents for rehabilitation or follow-up care related to TBI-caused hemiplegia, Coding Clinic guidance supports sequencing the S06.xx+S code (injury sequela) as the primary code and G81.xx as the manifestation per sequela coding rules.
• Spasticity and Botulinum Toxin: Coding Clinic guidance supports coding the specific type of hemiplegia (G81.1x — spastic) and using the I69.xx sequela code as a supporting diagnosis for botulinum toxin injections, when the spasticity is a direct consequence of a prior stroke.

💰 HCC / Risk Adjustment (v28)

Hemiplegia is a high-value condition in the CMS-HCC model v28. All G81.xx codes and all I69.xx sequela hemiplegia codes map to HCC 103 (Hemiplegia/Hemiparesis).

Annual Capture Requirements

For Medicare Advantage and ACO risk adjustment, HCC 103 must be captured in every calendar year to maintain the RAF credit. A diagnosis coded in year one does not carry forward. The most effective strategies for annual capture include:

1. Annual Wellness Visit (AWV): Provider must include hemiplegia (I69.35x preferred for post-stroke) on the problem list and document it as an active, ongoing condition in the encounter note.
2. Chronic Care Management (CCM) monthly touchpoints: Any billable encounter with a face-to-face component where hemiplegia is addressed qualifies.
3. Rehabilitation visits: PT/OT/SLP encounters document the functional deficit, supporting capture when the supervising physician also documents the diagnosis.

✍️ CDI Query Templates

🧑‍⚕️ Treatments (Clinical)

Rehabilitation — the Cornerstone

Comprehensive stroke and hemiplegia rehabilitation is the primary treatment. Per AHA/ASA Stroke Rehabilitation Guidelines, early intensive inpatient rehabilitation is associated with improved functional outcomes. Key components:

• Physical therapy (PT): Neurodevelopmental treatment (NDT/Bobath), task-specific training, gait training with or without body-weight support treadmill (BWSTT), FES for foot drop.
• Occupational therapy (OT): ADL retraining, upper extremity functional training, constraint-induced movement therapy (CIMT) — intensive protocol restricting the unaffected arm.
• Speech-language pathology (SLP): Dysphagia management (oral motor exercises, modified diet, videofluoroscopic swallowing study), aphasia rehabilitation, augmentative communication.

Spasticity Treatment Hierarchy

1. Conservative: Stretching, positioning, splinting, serial casting, oral medications (baclofen, tizanidine, dantrolene)
2. Chemodenervation: Botulinum toxin type A (onabotulinumtoxinA) injected into spastic muscles; repeat every 12–16 weeks; guided by EMG or ultrasound; most effective for focal spasticity
3. Intrathecal baclofen (ITB) pump: For severe generalized spasticity unresponsive to oral/chemodenervation therapy; implanted pump delivers baclofen directly to intrathecal space; requires ongoing refills (every 3–6 months)
4. Surgical: Selective dorsal rhizotomy (SDR) — primarily in pediatric spastic hemiplegia; tendon lengthening/transfer for fixed contractures

Orthotic and Assistive Technology

Ankle-foot orthoses (AFO, L1900 series) address foot drop and equinovarus. Custom molded AFOs are standard for spastic equinovarus. Wrist-hand orthoses (L3900 series) prevent hand contracture. Wheelchairs (E1130+) for patients unable to ambulate independently.

Neuroplasticity-Based Approaches

Constraint-induced movement therapy, robot-assisted therapy, repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), and virtual reality rehabilitation are supported by emerging evidence from AHA rehabilitation guidelines and ongoing clinical trials.

🎓 Patient Education / Summary

For patients and caregivers, hemiplegia following a stroke or brain injury means that one side of the body has significant weakness or paralysis. This can affect the arm, hand, leg, foot, and sometimes the face on the same side.

Key Points for Patients and Families

• Recovery is possible: The brain has the ability to reorganize itself (neuroplasticity). Consistent, intensive rehabilitation — physical, occupational, and speech therapy — provides the best chance of recovery.
• Spasticity management matters: Stiffness (spasticity) in the affected limbs is common months to years after stroke. Treatments include stretching, medications, and botulinum toxin injections. Early treatment prevents permanent contractures.
• Falls prevention is critical: Hemiplegic patients are at high risk for falls. Use prescribed assistive devices (cane, walker, AFO), install grab bars, and remove home hazards.
• Annual check-ins with your doctor: For Medicare patients, your insurance plan calculates your risk score based on conditions documented by your doctor each year. Hemiplegia must be re-documented at least once a year to maintain accurate coverage — even if your condition hasn’t changed.
• Community resources: The American Stroke Association and rehabilitation support groups offer resources, support groups, and educational materials.
• Emotional health: Depression is common after stroke-related hemiplegia. Mental health support, counseling, and peer support groups are important components of comprehensive care.

This guide is produced for certified coders, auditors, and clinical documentation improvement specialists. Clinical decisions should be made by qualified healthcare providers. For coding questions, refer to the FY2026 ICD-10-CM Official Coding Guidelines (CDC/NCHS).

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)